Document is current

Article History

Received: 4 April 2019

Revised: 18 September 2019

Accepted: 21 November 2019

First Online: 19 December 2019

Compliance with ethical standards

:

: Dr. Etsegenet Tizazu reports no conflicts of interest. Gina Chang reports no conflicts of interest. Dr. Joseph R. Berger reports grants from Biogen, during the conduct of the study and personal fees from Millennium/Takeda, personal fees from Merck-Sharpe-Dohme, personal fees from Novartis, personal fees from Biogen, personal fees from Roche/Genentech, and personal fees from Genzyme/Sanofi. He serves on the Scientific Advisory Boards of Excision-Bio and Inhibikase.

Free to read: This content has been made available to all.